NorthernBio
Chad A. DesJardin has extensive experience in financial leadership across various industries. Currently, Chad serves as Chief Financial Officer at NorthernBio, a preclinical CRO focused on targeted drug delivery and molecular biology. Prior to this, Chad held CFO positions at Supreme Machined Products, a global supplier of precision machined parts, and AGS Company Automotive Solutions, which manufactures automotive aftermarket products. Additionally, Chad was Vice President of Finance at Falding Capital Group, a private equity firm, and worked in audit and assurance at BDO USA, LLP. Chad's career began as a Staff Accountant at Ciulla, Smith & Dale, LLP, after serving as a Corporal in the United States Marine Corps. Chad holds a Bachelor of Business Administration in Accounting from Grand Valley State University's Seidman College of Business and an Associate of Arts with a business concentration from Grand Rapids Community College.
This person is not in any teams
This person is not in any offices
NorthernBio
At Northern Bio, better lives begin with science. We go beyond the conventional, applying advanced surgical techniques and research methodologies to target the source of the disease, thereby maximizing their impact and potential to transform lives. Just We are more than just our research. We are a collaborative community of scientists who believe in open communication, transparency, and strong partnerships. We partner with our sponsors, offering tailored solutions and expert guidance at every step. Our commitment to excellence, responsibility, and trust is unwavering, guiding us as we tackle some of the most challenging conditions in human health. With every experiment, every analysis, every discovery, we strive to make a difference. We’re driven by a desire to serve those in need, safeguard human and animal health, and push the boundaries of scientific knowledge. At Northern Bio, possibilities become reality, and better lives begin.